The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma

R Donne, A Lujambio - Hepatology, 2023 - journals.lww.com
The liver is the sixth most common site of primary cancer in humans and the fourth leading
cause of cancer‐related death in the world. Hepatocellular carcinoma (HCC) accounts for …

Cancer vaccines

LH Butterfield - Bmj, 2015 - bmj.com
Cancer vaccines are designed to promote tumor specific immune responses, particularly
cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines …

[HTML][HTML] Alpha-fetoprotein: Past, present, and future

YH Yeo, YT Lee, HR Tseng, Y Zhu, S You… - Hepatology …, 2024 - journals.lww.com
Alpha-fetoprotein (AFP) is a glycoprotein that plays an important role in immune regulation
with critical involvement in early human development and maintaining the immune balance …

Progress in human tumour immunology and immunotherapy

SA Rosenberg - Nature, 2001 - nature.com
Studies of the administration of interleukin-2 to patients with metastatic melanoma or kidney
cancer have shown that immunological manipulations can mediate the durable regression …

A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides

LH Butterfield, A Ribas, VB Dissette, Y Lee… - Clinical Cancer …, 2006 - aacrjournals.org
Abstract α-Fetoprotein (AFP) is a self protein expressed by fetal liver at high levels, but is
transcriptionally repressed at birth. AFP is up-regulated in hepatocellular carcinomas, and …

Alpha‐fetoprotein and hepatocellular carcinoma immunity

X Wang, Q Wang - Canadian Journal of Gastroenterology and …, 2018 - Wiley Online Library
Hepatocarcinoma is one of the most prevalent gastroenterological cancers in the world with
less effective therapy. As an oncofetal antigen and diagnostic marker for liver cancer, alpha …

Liver immunology

DP Bogdanos, B Gao… - Comprehensive …, 2013 - pmc.ncbi.nlm.nih.gov
The liver is the largest organ in the body and is generally regarded by non-immunologists as
not having lymphoid function. However, such is far from accurate. This review highlights the …

T-cell responses to HLA-A* 0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer

LH Butterfield, A Ribas, WS Meng… - Clinical Cancer …, 2003 - aacrjournals.org
Purpose: An existing immunological paradigm is that high concentrations of soluble protein
contribute to the maintenance of peripheral tolerance/ignorance to self protein. We tested …

A listing of human tumor antigens recognized by T cells: March 2004 update

L Novellino, C Castelli, G Parmiani - Cancer Immunology, Immunotherapy, 2005 - Springer
The technological advances occurred in the last few years have led to a great increase in
the number of tumor associated antigens (TAA) that are currently available for clinical …

[HTML][HTML] Immunotherapy for hepatocellular carcinoma: a 2021 update

C Kole, N Charalampakis, S Tsakatikas, M Vailas… - Cancers, 2020 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is the most common liver malignancy
associated with poor prognosis. Treatment options are limited partially due to resistance to …